Cite
HARVARD Citation
Maiti, S. et al. (2022). Active-site molecular docking of nigellidine with nucleocapsid–NSP2–MPro of COVID-19 and to human IL1R–IL6R and strong antioxidant role of Nigella sativa in experimental rats. Journal of drug targeting. pp. 511-521. [Online].